Hemideina has raised funds via a private placement
Hemideina has raised US$7.4 million. The capital raised will be used to fund product development in preparation for the first human studies.
Hemideina is a Melbourne-based private company that is set to disrupt the cochlear implant market through its proprietary mechanical signal processing technology, the Hera wireless implant system. The company aims to provide a paradigm shift in hearing implant performance that will lead to increased access and adoption of treatment.
Oaklins’ team in Australia acted as lead manager in this transaction. The team has assisted Hemideina with fundraising since 2018 and is proud to support them on their mission to positively impact the lives of people with severe-to-profound hearing loss.
Elizabeth Williams
CEO and Co-founder, Hemideina
Sprechen Sie mit dem Deal Team
Transaktionen
INNOTEX has been acquired by Clearspring Capital Partners
INNOTEX, a manufacturer of personal protective equipment for firefighters and first responders, has completed a strategic partnership with Clearspring Capital Partners.
Mehr erfahrenGaraio AG (GARAIO) wurde von der Netrics Gruppe übernommen
Die Netrics Gruppe übernimmt GARAIO als 100%-ige Tochtergesellschaft. GARAIO wird als eigenständiges Unternehmen unter dem Dach der Netrics Gruppe weitergeführt.
Mit der Übernahme baut die Netrics Gruppe ihre führende Position als Anbieterin von Managed-Cloud und Digital-Workplace-Lösungen sowie Consulting-Dienstleistungen weiter aus.
Aptic has received a minority investment from Sofiouest
The shareholders of Aptic have completed a primary minority LBO with Sofiouest.
Mehr erfahren